Cargando…

Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma

The present study aimed to investigate the histological changes caused by neoadjuvant chemotherapy (NAC) for pancreatic ductal adenocarcinoma (PDAC), and to demonstrate the use of time-density curves (TDCs) of dynamic contrast-enhanced computed tomography (CECT) for determination of the histological...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Shintaro, Yoshizawa, Tadashi, Ishido, Keinosuke, Seino, Hiroko, Morohashi, Satoko, Ogasawara, Hirokazu, Kubota, Shunsuke, Ogasawara, Kenta, Nakamura, Akie, Hakamada, Kenichi, Kijima, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942254/
https://www.ncbi.nlm.nih.gov/pubmed/36799183
http://dx.doi.org/10.3892/or.2023.8498
_version_ 1784891458867691520
author Goto, Shintaro
Yoshizawa, Tadashi
Ishido, Keinosuke
Seino, Hiroko
Morohashi, Satoko
Ogasawara, Hirokazu
Kubota, Shunsuke
Ogasawara, Kenta
Nakamura, Akie
Hakamada, Kenichi
Kijima, Hiroshi
author_facet Goto, Shintaro
Yoshizawa, Tadashi
Ishido, Keinosuke
Seino, Hiroko
Morohashi, Satoko
Ogasawara, Hirokazu
Kubota, Shunsuke
Ogasawara, Kenta
Nakamura, Akie
Hakamada, Kenichi
Kijima, Hiroshi
author_sort Goto, Shintaro
collection PubMed
description The present study aimed to investigate the histological changes caused by neoadjuvant chemotherapy (NAC) for pancreatic ductal adenocarcinoma (PDAC), and to demonstrate the use of time-density curves (TDCs) of dynamic contrast-enhanced computed tomography (CECT) for determination of the histological therapeutic effects of NAC for PDAC. A total of 96 patients with PDAC were examined; 46 underwent NAC (NAC group) and 50 did not undergo NAC (non-NAC group). Based on histological therapeutic effect and using the area of residual tumor (ART) grading system, the NAC group was divided into low-responders and high-responders. Histological analysis was used to evaluate the densities of cancer cells, cancer-associated fibroblasts (CAFs), microvessels and stromal collagen fibers in the NAC and non-NAC groups. Radiological analysis was used to evaluate the TDCs of three slopes of the NAC group, namely slopes between the non-contrast and arterial phases (δ1 and δ1′), between the arterial and portal phases (δ2 and δ2′), and between the portal and equilibrium phases (δ3 and δ3′). δ1-δ3 were before NAC, whereas δ1′-δ3′ were after NAC. Changes in δ1, δ2 and δ3 before and after NAC were denoted as δδ1 (=δ1′-δ1), δδ2 (=δ2′-δ2) and δδ3 (=δ3′-δ3). ART grading system, histological examination and radiological examination data were also statistically analyzed. Histological examination revealed a significant decrease in cancer cells and CAFs, and a significant increase in stromal collagen fibers due to NAC (P<0.01). Radiological examination revealed that δ1′ was significantly higher than δ1 in low-responders (P<0.05), whereas δ2′ was significantly lower than δ2 in high-responders (P<0.01). δδ2 was significantly lower and δδ3 was significantly higher in high-responders than in low-responders (P<0.01 and P<0.05, respectively). Receiver operating characteristic curve showed that δδ2 and δδ3 were effective indicators of the histological therapeutic effect of NAC. In conclusion, the TDC of dynamic CECT may be useful for determining the histological therapeutic effect of NAC for PDAC.
format Online
Article
Text
id pubmed-9942254
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-99422542023-02-22 Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma Goto, Shintaro Yoshizawa, Tadashi Ishido, Keinosuke Seino, Hiroko Morohashi, Satoko Ogasawara, Hirokazu Kubota, Shunsuke Ogasawara, Kenta Nakamura, Akie Hakamada, Kenichi Kijima, Hiroshi Oncol Rep Articles The present study aimed to investigate the histological changes caused by neoadjuvant chemotherapy (NAC) for pancreatic ductal adenocarcinoma (PDAC), and to demonstrate the use of time-density curves (TDCs) of dynamic contrast-enhanced computed tomography (CECT) for determination of the histological therapeutic effects of NAC for PDAC. A total of 96 patients with PDAC were examined; 46 underwent NAC (NAC group) and 50 did not undergo NAC (non-NAC group). Based on histological therapeutic effect and using the area of residual tumor (ART) grading system, the NAC group was divided into low-responders and high-responders. Histological analysis was used to evaluate the densities of cancer cells, cancer-associated fibroblasts (CAFs), microvessels and stromal collagen fibers in the NAC and non-NAC groups. Radiological analysis was used to evaluate the TDCs of three slopes of the NAC group, namely slopes between the non-contrast and arterial phases (δ1 and δ1′), between the arterial and portal phases (δ2 and δ2′), and between the portal and equilibrium phases (δ3 and δ3′). δ1-δ3 were before NAC, whereas δ1′-δ3′ were after NAC. Changes in δ1, δ2 and δ3 before and after NAC were denoted as δδ1 (=δ1′-δ1), δδ2 (=δ2′-δ2) and δδ3 (=δ3′-δ3). ART grading system, histological examination and radiological examination data were also statistically analyzed. Histological examination revealed a significant decrease in cancer cells and CAFs, and a significant increase in stromal collagen fibers due to NAC (P<0.01). Radiological examination revealed that δ1′ was significantly higher than δ1 in low-responders (P<0.05), whereas δ2′ was significantly lower than δ2 in high-responders (P<0.01). δδ2 was significantly lower and δδ3 was significantly higher in high-responders than in low-responders (P<0.01 and P<0.05, respectively). Receiver operating characteristic curve showed that δδ2 and δδ3 were effective indicators of the histological therapeutic effect of NAC. In conclusion, the TDC of dynamic CECT may be useful for determining the histological therapeutic effect of NAC for PDAC. D.A. Spandidos 2023-02-13 /pmc/articles/PMC9942254/ /pubmed/36799183 http://dx.doi.org/10.3892/or.2023.8498 Text en Copyright: © Goto et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Goto, Shintaro
Yoshizawa, Tadashi
Ishido, Keinosuke
Seino, Hiroko
Morohashi, Satoko
Ogasawara, Hirokazu
Kubota, Shunsuke
Ogasawara, Kenta
Nakamura, Akie
Hakamada, Kenichi
Kijima, Hiroshi
Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma
title Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma
title_full Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma
title_fullStr Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma
title_full_unstemmed Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma
title_short Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma
title_sort use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942254/
https://www.ncbi.nlm.nih.gov/pubmed/36799183
http://dx.doi.org/10.3892/or.2023.8498
work_keys_str_mv AT gotoshintaro useoftimedensitycurvesofdynamiccontrastenhancedcomputedtomographyfordeterminationofthehistologicaltherapeuticeffectsofneoadjuvantchemotherapyforpancreaticductaladenocarcinoma
AT yoshizawatadashi useoftimedensitycurvesofdynamiccontrastenhancedcomputedtomographyfordeterminationofthehistologicaltherapeuticeffectsofneoadjuvantchemotherapyforpancreaticductaladenocarcinoma
AT ishidokeinosuke useoftimedensitycurvesofdynamiccontrastenhancedcomputedtomographyfordeterminationofthehistologicaltherapeuticeffectsofneoadjuvantchemotherapyforpancreaticductaladenocarcinoma
AT seinohiroko useoftimedensitycurvesofdynamiccontrastenhancedcomputedtomographyfordeterminationofthehistologicaltherapeuticeffectsofneoadjuvantchemotherapyforpancreaticductaladenocarcinoma
AT morohashisatoko useoftimedensitycurvesofdynamiccontrastenhancedcomputedtomographyfordeterminationofthehistologicaltherapeuticeffectsofneoadjuvantchemotherapyforpancreaticductaladenocarcinoma
AT ogasawarahirokazu useoftimedensitycurvesofdynamiccontrastenhancedcomputedtomographyfordeterminationofthehistologicaltherapeuticeffectsofneoadjuvantchemotherapyforpancreaticductaladenocarcinoma
AT kubotashunsuke useoftimedensitycurvesofdynamiccontrastenhancedcomputedtomographyfordeterminationofthehistologicaltherapeuticeffectsofneoadjuvantchemotherapyforpancreaticductaladenocarcinoma
AT ogasawarakenta useoftimedensitycurvesofdynamiccontrastenhancedcomputedtomographyfordeterminationofthehistologicaltherapeuticeffectsofneoadjuvantchemotherapyforpancreaticductaladenocarcinoma
AT nakamuraakie useoftimedensitycurvesofdynamiccontrastenhancedcomputedtomographyfordeterminationofthehistologicaltherapeuticeffectsofneoadjuvantchemotherapyforpancreaticductaladenocarcinoma
AT hakamadakenichi useoftimedensitycurvesofdynamiccontrastenhancedcomputedtomographyfordeterminationofthehistologicaltherapeuticeffectsofneoadjuvantchemotherapyforpancreaticductaladenocarcinoma
AT kijimahiroshi useoftimedensitycurvesofdynamiccontrastenhancedcomputedtomographyfordeterminationofthehistologicaltherapeuticeffectsofneoadjuvantchemotherapyforpancreaticductaladenocarcinoma